Global Emphysema Treatment Market to Grow at a Healthy Pace During 2021-2026, Aided by the Growing R&D Activities

The emphysema treatment industry is expected to be driven by the growing R&D activities to develop the novel treatment for emphysema. There has been a rise in the number of patients suffering from COPD and asthma in the past few years. The new approvals by the FDA for novel products and the increasing government initiatives to control COPD and asthma are significantly contributing to the market growth.  The use of drugs, which has emerged as an effective solution to treat COPD and asthma, and their wide acceptance among the patients are, in turn, aiding the emphysema treatment industry growth.

Further, the expanding pharmaceutical industry in developing nations, such as China and India, provides huge growth opportunities for the market expansion. The introduction of generic drugs to this market is expected to further propel the industry growth in the coming years. Some of the leading players in the industry include Pulmonx Corp (NASDAQ: LUNG) and Pfizer Inc. (NYSE: PFE). In May 2021, Pulmonx announced that the company had secured USD 66 million in financing from Ally Bridge Group, a leading global life science investor, to support the commercial acceleration of the zephyr valve system, a minimally invasive treatment for severe emphysema. Such developments are expected to significantly aid the industry growth in the forecast period.

Market Breakup by Treatment, Types of Diseases, End Use, and Region:

• Based on treatment, the industry can be segmented into smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, and surgery transplant, among others. 
• The industry can be categorised based on types of diseases into shortness of breath, chronic cough, chronic mucous production, chest tightness, wheezing, fatigue, lowered immunity, weight loss, and thin and very pink skin, among others. 
• On the basis of end use sectors, the industry is divided into hospitals, clinics, and surgical centres, among others.
• Region-wise, the global market for emphysema treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for emphysema treatment is driven by the increase in the number of smoking population and growing prevalence of chronic lung disorders. 
• The changing dietary habits, busy lifestyle, and rapid industrialisation are also contributing to the industry growth. 
• The market is receiving a further impetus with the advancing medical sector and the growing awareness regarding chronic obstructive pulmonary disease (COPD). 
• The increasing investments in R&D activities and the growing efforts to develop minimally invasive treatment procedures are further propelling the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for emphysema treatment for the periods (2016-2020) and (2021-2026). 
• The report also offers historical (2016-2020) and forecast (2021-2026) market information for the treatments, types of diseases, end uses, and major regions of emphysema treatment.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global emphysema treatment market are Pulmonx Corporation, Kamada Limited, Pfizer Inc., and Uptake Medical Technology Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790